? Project 3 Project 3 will investigate the physical and metabolic constraints of cancer cell invasion. Cancer cell invasion from the primary tumor into surrounding tissues is a crucial step of the metastatic cascade, which is responsible for the vast majority of all cancer deaths. Invading cancer cells can use a number of different `migration modes' for this process. As cells can dynamically switch between these modes, therapeutic attempts to target specific migration mechanisms have had limited clinical success. Gaining an improved understanding of the physical and biological mechanisms that govern the toggling between different migration modes could provide new clues for more robust therapeutic interference to reduce or eliminate metastasis. One important factor that has not been examined previously is how the metabolic status of individual cells can determine their migration mode and metastatic spreading. As cancer cells pass through tight interstitial spaces and metabolite- poor regions in vivo, they face substantial physical and metabolic challenges. We propose that invading cancer cells must expend significant energy to penetrate such environments and adopt migration modes that minimize metabolic cost. Cancer cell metabolism can also impact cellular structure and composition by fueling biosynthetic pathways, which could alter cell surface architecture and nuclear deformability, and thereby promote migration through tight spaces. The proposed research will utilize the project team's complementary expertise in cell migration, subcellular biomechanics, intravital microscopy, and metabolic pathways and interference.
Aim 1 addresses how the physical microenvironment and adhesion/friction between the cell and the extracellular environment determine energy consumption during different types of cell migration.
Aim 2 will investigate how physical factors intrinsic to the cell, particularly nuclear deformability and the physical properties of the cell surface, modulate metabolic cost and migration efficiency in physiologically relevant environments. It will further determine how metabolic reprogramming in cancer cells affects these cellular mechanical properties and thereby modulates migration efficiency.
Aim 3 will investigate the plasticity of cancer cell migration, both in response to varying physical and metabolic challenges and to pharmacological interference. The experimental work in each aim will be complemented by modeling of cancer cell metabolism and physical interaction with the microenvironment, with the objective to predict outcomes of therapeutic metabolic interventions and to identify strategies to counter adaptive responses. Project 3 will interact with both Cores. The Tissue Microfabrication Core will provide biological samples and platforms for migration assays; the Biophysics & Metabolic Imaging Core assists with metabolic analysis and imaging platforms. Projects 1 and 2 will contribute data and insights for a comprehensive computational modeling framework of cell metabolism in migration; Project 2 will additionally provide tumor microvesicles for functional evaluation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA210184-05
Application #
10020781
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Cornell University
Department
Type
DUNS #
872612445
City
Ithaca
State
NY
Country
United States
Zip Code
14850
Zahid, H; Subbaramaiah, K; Iyengar, N M et al. (2018) Leptin regulation of the p53-HIF1?/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer link. Int J Obes (Lond) 42:711-720
Hopkins, Benjamin D; Pauli, Chantal; Du, Xing et al. (2018) Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature 560:499-503
Croessmann, Sarah; Sheehan, Jonathan H; Lee, Kyung-Min et al. (2018) PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K? Inhibitors. Clin Cancer Res 24:1426-1435
Puca, Loredana; Bareja, Rohan; Prandi, Davide et al. (2018) Patient derived organoids to model rare prostate cancer phenotypes. Nat Commun 9:2404
van Helvert, Sjoerd; Storm, Cornelis; Friedl, Peter (2018) Mechanoreciprocity in cell migration. Nat Cell Biol 20:8-20
Beunk, Lianne; Brown, Kari; Nagtegaal, Iris et al. (2018) Cancer invasion into musculature: Mechanics, molecules and implications. Semin Cell Dev Biol :
Lourenço, Bianca N; Springer, Nora L; Ferreira, Daniel et al. (2018) CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling. Integr Biol (Camb) 10:145-158
Elacqua, Joshua J; McGregor, Alexandra L; Lammerding, Jan (2018) Automated analysis of cell migration and nuclear envelope rupture in confined environments. PLoS One 13:e0195664
Yadav, Sandeep Kumar; Feigelson, Sara W; Roncato, Francesco et al. (2018) Frontline Science: Elevated nuclear lamin A is permissive for granulocyte transendothelial migration but not for motility through collagen I barriers. J Leukoc Biol 104:239-251
Takai, Ken; Drain, Allison P; Lawson, Devon A et al. (2018) Discoidin domain receptor 1 (DDR1) ablation promotes tissue fibrosis and hypoxia to induce aggressive basal-like breast cancers. Genes Dev 32:244-257

Showing the most recent 10 out of 46 publications